Insulin degludec in a flexible daily dosing regimen provides similar glycaemic control without increasing rates of hypoglycaemia compared to dosing the same time daily in type 2 diabetes
Main Authors: | , , , , , , , , , |
---|---|
Format: | Conference item |
Published: |
2011
|
Summary: |
---|